Sfoglia per Titolo
Phase III trial comparing 3 to 6 months of adjuvant FOLFOX4/XELOX in stage II-III colon cancer: safety and compliance in the TOSCA trial
2016-01-01 Lonardi, S; Sobrero, A; Rosati, G; Di Bartolomeo, M; Ronzoni, M; Aprile, G; Scartozzi, M; Banzi, M; Zampino, Mg; Pasini, F; Marchetti, P; Cantore, M; Zaniboni, A; Rimassa, L; Ciuffreda, L; Ferrari, D; Barni, S; Zagonel, V; Maiello, E; Rulli, E; Labianca, R; On behalf of TOSCA (Three Or Six Colon Adjuvant), Investigators
Phase III trial comparing protracted intravenous fluorouracil infusion alone or with yttrium-90 resin microspheres radioembolization for liver-limited metastatic colorectal cancer refractory to standard chemotherapy
2010-01-01 Hendlisz, A.; Van Den Eynde, M.; Peeters, M.; Maleux, G.; Lambert, B.; Vannoote, J.; De Keukeleire, K.; Verslype, C.; Defreyne, L.; Van Cutsem, E.; Delatte, P.; Delaunoit, T.; Personeni, N.; Paesmans, M.; Van Laethem, J.; Flamen, P.
Phase III Trial Comparing Vinflunine With Docetaxel in Second-Line Advanced Non-Small-Cell Lung Cancer Previously Treated With Platinum-Containing Chemotherapy
2010-01-01 Krzakowski, M; Ramlau, R; Jassem, J; Szczesna, A; Zatloukal, P; Von Pawel, J; Sun, X; Bennouna, J; Santoro, A; Biesma, B; Delgado, F M; Salhi, Y; Vaissiere, N; Hansen, O; Tan, Eh; Quoix, E; Garrido, P; Douillard, Jy; Ri, Gp
Phase III trial of gemcitabine compared with pegylated liposomal doxorubicin in progressive or recurrent ovarian cancer
2008-01-01 Ferrandina, Gabriella; Ludovisi, Manuela; Lorusso, D; Pignata, Sandro; Breda, Enrico; Savarese, Antonella; Del Medico, Pietro; Scaltriti, Laura; Katsaros, Dionyssios; Priolo, Domenico; Scambia, Giovanni
Phase III trial of pemetrexed plus best supportive care compared with best supportive care in previously treated patients with advanced malignant pleural mesothelioma
2008-01-01 Jassem, J; Ramlau, R; Santoro, A; Schuette, W; Chemaissani, A; Hong, S; Blatter, J; Adachi, S; Hanauske, A; Manegold, C
Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Gemcitabine/Cisplatin Alone or With Sorafenib for the First-Line Treatment of Advanced, Nonsquamous Non-Small-Cell Lung Cancer.
2012-01-01 Paz-Ares, L G; Biesma, B; Heigener, D; Von, P J; Eisen, T; Bennouna, J; Zhang, L; Liao, M; Sun, Y; Gans, S; Syrigos, K; Le Marie, E; Gottfried, M; Vansteenkiste, J; Alberola, V; Strauss, U P; Montegriffo, E; Ong, T J; Santoro, A
Phase IV trial of dose-intense PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) in advanced pancreatic adenocarcinoma.
2006-01-01 Reni, M; Cereda, S; Passoni, P; Bonetto, E; Vigano, Mg; Balzano, G; Zerbi, A; Staudacher, C; Di Carlo, V
Phase Lib trial of tivantinib in combination with carboplatin and pernetrexed as first-line treatment in patients (pts) with advanced nonsquamous NSCLC or malignant pleural mesotheliorna (MPM)
2014-01-01 Zucali, Pa; Simonelli, M; De Vincenzo, F; Fatuzzo, G; Bertossl, M; Suter, Mb; Perrino, M; Giordano, L; Santoro, A
A Phase-1b study of tivantinib (ARQ 197) in adult patients with hepatocellular carcinoma and cirrhosis
2013-01-01 Santoro, A; Simonelli, M; Rodriguez-Lope, C; Zucali, P; Camacho, Lh; Granito, A; Senzer, N; Rimassa, L; Abbadessa, G; Schwartz, B; Lamar, M; Savage, Re; Bruix, J
PHASE-II STUDY OF FOTEMUSTINE IN ADVANCED SOFT-TISSUE SARCOMAS - A TRIAL OF THE EORTC SOFT-TISSUE AND BONE SARCOMA GROUP
1993-01-01 Kerbrat, P; Somers, R; Verweij, J; Crowther, D; Tursz, T; Santoro, A; Steward, Wp; Lentz, Ma; Vanglabbeke, M; Mouridsen, Ht
PHASE-II STUDY OF MITOZOLOMIDE IN ADVANCED SOFT-TISSUE SARCOMA OF ADULTS - THE EORTC SOFT-TISSUE AND BONE SARCOMA GROUP
1992-01-01 Somers, R; Santoro, A; Verweij, J; Lucas, P; Rouesse, J; Kok, T; Casali, A; Seynaeve, C; Thomas, D
PHD1 regulates p53-mediated colorectal cancer chemoresistance
2015-01-01 Deschoemaeker, S.; Di Conza, G.; Lilla, S.; Martin-Perez, R.; Mennerich, D.; Boon, L.; Hendrikx, S.; Maddocks, O. D.; Marx, C.; Radhakrishnan, P.; Prenen, H.; Schneider, M.; Myllyharju, J.; Kietzmann, T.; Vousden, K. H.; Zanivan, S.; Mazzone, M.
PHD2 inhibition for blood vessel normalization, and uses thereof
2010-01-01 Mazzone, M; Carmeliet, P
PHD2 regulates arteriogenic macrophages through TIE2 signalling
2013-01-01 Hamm, A.; Veschini, L.; Takeda, Y.; Costa, S.; Delamarre, E.; Squadrito, M. L.; Henze, A. -T.; Wenes, M.; Serneels, J.; Pucci, F.; Roncal, C.; Anisimov, A.; Alitalo, K.; De Palma, M.; Mazzone, M.
PHD2 Targeting Overcomes Breast Cancer Cell Death upon Glucose Starvation in a PP2A/B55α-Mediated Manner
2017-01-01 Di Conza, G.; Trusso Cafarello, S.; Zheng, X.; Zhang, Q.; Mazzone, M.
Phenomenology of spontaneous closure in degenerative and mixed type lamellar macular hole
2023-01-01 Catania, Fiammetta; Romano, Mario; Crincoli, Emanuele; Allegrini, Davide; Miere, Alexandra; Chehaibou, Ismael; Abdelmassih, Youssef; Beaumont, William; Chapron, Thibaut; Souied, Eric H; Caputo, Georges
Phenotype and function of dendritic cells and T-lymphocyte polarization in the human colonic mucosa and adenocarcinoma
2008-01-01 Gianotti, L.; Sargenti, M.; Galbiati, F.; Nespoli, L.; Brivio, F.; Rescigno, M.; Nespoli, A.
Phenotype of limited cutaneous systemic sclerosis patients with positive anti-topoisomerase I antibodies: data from EUSTAR cohort
2022-01-01 Elisabetta, Zanatta; Dörte, Huscher; Augusta, Ortolan; Jérôme, Avouac; Paolo, Airò; Alexandra, Balbir-Gurman; Elise, Siegert; Marco Matucci, Cerinic; Franco, Cozzi; Gabriela, Riemekasten; Anna-Maria, Hoffmann-Vold; Oliver, Distler; Armando, Gabrielli; Stefan, Heitmann; Nicolas, Hunzelmann; Carlomaurizio, Montecucco; Jadranka, Morovic-Vergles; Camillo, Ribi; Andrea, Doria; Yannick, Allanore; Cuomo, Giovanna; Moroncini, Gianluca; Stork, Jiri; Iannone, Fiorenzo; Walker, Ulrich; Bertoldo, Eugenia; Krasowska, Dorota; João Salvador, Maria; Tikly, Mohammed; Hachulla, Eric; Riccieri, Valeria; Sha, Ami; Maria Gheorghiu, Ana; Sunderkötter, Cord; Ingegnoli, Francesca; Mouthon, Luc; Smith, Vanessa; Paolo Cantatore, Francesco; Eyerich, Kilian; Wiland, Piotr; Vanthuyne, Marie; Anic, Branimir; Üprus, Maria; Granel, Brigitte; Vacca, Alessandra; Tanaseanu, Cristina-Mihaela; García de la Peña Lefebvre, Paloma; Sibilia, Jean; Litinsky, Ira; Ann Saketkoo, Lesley; Kerzberg, Eduardo; Limonta, Massimiliano; Rimar, Doron; Sfikakis, Petros; Cutolo, Maurizio; E Carreira, Patricia; Foti, Rosario; Novak, Srdan; Iudici, Michele; Radic, Mislav; Pellerito, Raffaele; Selmi, Carlo Francesco; P Ananieva, Lidia; Szücs, Gabriela; de la Puente, Carlos; Maria Ionescu, Ruxandra; Distler, Jörg; Rosa Pozzi, Maria; Jose Alegre-Sancho, Juan; Herrmann, Kristine; De Langhe, Ellen; Yavuz Altunizade, Sule; de Souza Müller, Carolina; Agachi, Svetlana; Veale, Douglas; Loyo, Esthela; Li, Mengtao; Rosato, Edoardo; Maurer, Britta; Castellví, Ivan; Spertini, François; Solanki, Kamal; Del Papa, Nicoletta; Espinosa, Gerard; Czirják, László; Coleiro, Bernard; Farge Bancel, Dominique; Pellerito, Raffaele; Denton, Christopher; Damjanov, Nemanja; Henes, Jörg; Ortiz Santamaria Granollers, Vera; Kohm, Michaela; Stamenkovic, Bojana
Phenotypic and functional analysis at the clonal level of infiltrating T lymphocytes in papillary carcinoma of the thyroid: prevalence of cytolytic T cells with natural killer-like or lymphokine-activated killer activity
1989-01-01 Bagnasco, M; Venuti, D; Paolieri, F; Torre, G; Ferrini, S; Canonica, Gw
Phenotypic and genotypic Helicobacter pylori clarithromycin resistance and therapeutic outcome: benefits and limits
2010-01-01 De Francesco, V; Zullo, A; Ierardi, E; Giorgio, F; Perna, Francesco; Hassan, Cesare; Morini, S; Panella, C; Vaira, D.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Phase III trial comparing 3 to 6 months of adjuvant FOLFOX4/XELOX in stage II-III colon cancer: safety and compliance in the TOSCA trial | 1-gen-2016 | Lonardi, S; Sobrero, A; Rosati, G; Di Bartolomeo, M; Ronzoni, M; Aprile, G; Scartozzi, M; Banzi, M; Zampino, Mg; Pasini, F; Marchetti, P; Cantore, M; Zaniboni, A; Rimassa, L; Ciuffreda, L; Ferrari, D; Barni, S; Zagonel, V; Maiello, E; Rulli, E; Labianca, R; On behalf of TOSCA (Three Or Six Colon Adjuvant), Investigators | |
| Phase III trial comparing protracted intravenous fluorouracil infusion alone or with yttrium-90 resin microspheres radioembolization for liver-limited metastatic colorectal cancer refractory to standard chemotherapy | 1-gen-2010 | Hendlisz, A.; Van Den Eynde, M.; Peeters, M.; Maleux, G.; Lambert, B.; Vannoote, J.; De Keukeleire, K.; Verslype, C.; Defreyne, L.; Van Cutsem, E.; Delatte, P.; Delaunoit, T.; Personeni, N.; Paesmans, M.; Van Laethem, J.; Flamen, P. | |
| Phase III Trial Comparing Vinflunine With Docetaxel in Second-Line Advanced Non-Small-Cell Lung Cancer Previously Treated With Platinum-Containing Chemotherapy | 1-gen-2010 | Krzakowski, M; Ramlau, R; Jassem, J; Szczesna, A; Zatloukal, P; Von Pawel, J; Sun, X; Bennouna, J; Santoro, A; Biesma, B; Delgado, F M; Salhi, Y; Vaissiere, N; Hansen, O; Tan, Eh; Quoix, E; Garrido, P; Douillard, Jy; Ri, Gp | |
| Phase III trial of gemcitabine compared with pegylated liposomal doxorubicin in progressive or recurrent ovarian cancer | 1-gen-2008 | Ferrandina, Gabriella; Ludovisi, Manuela; Lorusso, D; Pignata, Sandro; Breda, Enrico; Savarese, Antonella; Del Medico, Pietro; Scaltriti, Laura; Katsaros, Dionyssios; Priolo, Domenico; Scambia, Giovanni | |
| Phase III trial of pemetrexed plus best supportive care compared with best supportive care in previously treated patients with advanced malignant pleural mesothelioma | 1-gen-2008 | Jassem, J; Ramlau, R; Santoro, A; Schuette, W; Chemaissani, A; Hong, S; Blatter, J; Adachi, S; Hanauske, A; Manegold, C | |
| Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Gemcitabine/Cisplatin Alone or With Sorafenib for the First-Line Treatment of Advanced, Nonsquamous Non-Small-Cell Lung Cancer. | 1-gen-2012 | Paz-Ares, L G; Biesma, B; Heigener, D; Von, P J; Eisen, T; Bennouna, J; Zhang, L; Liao, M; Sun, Y; Gans, S; Syrigos, K; Le Marie, E; Gottfried, M; Vansteenkiste, J; Alberola, V; Strauss, U P; Montegriffo, E; Ong, T J; Santoro, A | |
| Phase IV trial of dose-intense PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) in advanced pancreatic adenocarcinoma. | 1-gen-2006 | Reni, M; Cereda, S; Passoni, P; Bonetto, E; Vigano, Mg; Balzano, G; Zerbi, A; Staudacher, C; Di Carlo, V | |
| Phase Lib trial of tivantinib in combination with carboplatin and pernetrexed as first-line treatment in patients (pts) with advanced nonsquamous NSCLC or malignant pleural mesotheliorna (MPM) | 1-gen-2014 | Zucali, Pa; Simonelli, M; De Vincenzo, F; Fatuzzo, G; Bertossl, M; Suter, Mb; Perrino, M; Giordano, L; Santoro, A | |
| A Phase-1b study of tivantinib (ARQ 197) in adult patients with hepatocellular carcinoma and cirrhosis | 1-gen-2013 | Santoro, A; Simonelli, M; Rodriguez-Lope, C; Zucali, P; Camacho, Lh; Granito, A; Senzer, N; Rimassa, L; Abbadessa, G; Schwartz, B; Lamar, M; Savage, Re; Bruix, J | |
| PHASE-II STUDY OF FOTEMUSTINE IN ADVANCED SOFT-TISSUE SARCOMAS - A TRIAL OF THE EORTC SOFT-TISSUE AND BONE SARCOMA GROUP | 1-gen-1993 | Kerbrat, P; Somers, R; Verweij, J; Crowther, D; Tursz, T; Santoro, A; Steward, Wp; Lentz, Ma; Vanglabbeke, M; Mouridsen, Ht | |
| PHASE-II STUDY OF MITOZOLOMIDE IN ADVANCED SOFT-TISSUE SARCOMA OF ADULTS - THE EORTC SOFT-TISSUE AND BONE SARCOMA GROUP | 1-gen-1992 | Somers, R; Santoro, A; Verweij, J; Lucas, P; Rouesse, J; Kok, T; Casali, A; Seynaeve, C; Thomas, D | |
| PHD1 regulates p53-mediated colorectal cancer chemoresistance | 1-gen-2015 | Deschoemaeker, S.; Di Conza, G.; Lilla, S.; Martin-Perez, R.; Mennerich, D.; Boon, L.; Hendrikx, S.; Maddocks, O. D.; Marx, C.; Radhakrishnan, P.; Prenen, H.; Schneider, M.; Myllyharju, J.; Kietzmann, T.; Vousden, K. H.; Zanivan, S.; Mazzone, M. | |
| PHD2 inhibition for blood vessel normalization, and uses thereof | 1-gen-2010 | Mazzone, M; Carmeliet, P | |
| PHD2 regulates arteriogenic macrophages through TIE2 signalling | 1-gen-2013 | Hamm, A.; Veschini, L.; Takeda, Y.; Costa, S.; Delamarre, E.; Squadrito, M. L.; Henze, A. -T.; Wenes, M.; Serneels, J.; Pucci, F.; Roncal, C.; Anisimov, A.; Alitalo, K.; De Palma, M.; Mazzone, M. | |
| PHD2 Targeting Overcomes Breast Cancer Cell Death upon Glucose Starvation in a PP2A/B55α-Mediated Manner | 1-gen-2017 | Di Conza, G.; Trusso Cafarello, S.; Zheng, X.; Zhang, Q.; Mazzone, M. | |
| Phenomenology of spontaneous closure in degenerative and mixed type lamellar macular hole | 1-gen-2023 | Catania, Fiammetta; Romano, Mario; Crincoli, Emanuele; Allegrini, Davide; Miere, Alexandra; Chehaibou, Ismael; Abdelmassih, Youssef; Beaumont, William; Chapron, Thibaut; Souied, Eric H; Caputo, Georges | |
| Phenotype and function of dendritic cells and T-lymphocyte polarization in the human colonic mucosa and adenocarcinoma | 1-gen-2008 | Gianotti, L.; Sargenti, M.; Galbiati, F.; Nespoli, L.; Brivio, F.; Rescigno, M.; Nespoli, A. | |
| Phenotype of limited cutaneous systemic sclerosis patients with positive anti-topoisomerase I antibodies: data from EUSTAR cohort | 1-gen-2022 | Elisabetta, Zanatta; Dörte, Huscher; Augusta, Ortolan; Jérôme, Avouac; Paolo, Airò; Alexandra, Balbir-Gurman; Elise, Siegert; Marco Matucci, Cerinic; Franco, Cozzi; Gabriela, Riemekasten; Anna-Maria, Hoffmann-Vold; Oliver, Distler; Armando, Gabrielli; Stefan, Heitmann; Nicolas, Hunzelmann; Carlomaurizio, Montecucco; Jadranka, Morovic-Vergles; Camillo, Ribi; Andrea, Doria; Yannick, Allanore; Cuomo, Giovanna; Moroncini, Gianluca; Stork, Jiri; Iannone, Fiorenzo; Walker, Ulrich; Bertoldo, Eugenia; Krasowska, Dorota; João Salvador, Maria; Tikly, Mohammed; Hachulla, Eric; Riccieri, Valeria; Sha, Ami; Maria Gheorghiu, Ana; Sunderkötter, Cord; Ingegnoli, Francesca; Mouthon, Luc; Smith, Vanessa; Paolo Cantatore, Francesco; Eyerich, Kilian; Wiland, Piotr; Vanthuyne, Marie; Anic, Branimir; Üprus, Maria; Granel, Brigitte; Vacca, Alessandra; Tanaseanu, Cristina-Mihaela; García de la Peña Lefebvre, Paloma; Sibilia, Jean; Litinsky, Ira; Ann Saketkoo, Lesley; Kerzberg, Eduardo; Limonta, Massimiliano; Rimar, Doron; Sfikakis, Petros; Cutolo, Maurizio; E Carreira, Patricia; Foti, Rosario; Novak, Srdan; Iudici, Michele; Radic, Mislav; Pellerito, Raffaele; Selmi, Carlo Francesco; P Ananieva, Lidia; Szücs, Gabriela; de la Puente, Carlos; Maria Ionescu, Ruxandra; Distler, Jörg; Rosa Pozzi, Maria; Jose Alegre-Sancho, Juan; Herrmann, Kristine; De Langhe, Ellen; Yavuz Altunizade, Sule; de Souza Müller, Carolina; Agachi, Svetlana; Veale, Douglas; Loyo, Esthela; Li, Mengtao; Rosato, Edoardo; Maurer, Britta; Castellví, Ivan; Spertini, François; Solanki, Kamal; Del Papa, Nicoletta; Espinosa, Gerard; Czirják, László; Coleiro, Bernard; Farge Bancel, Dominique; Pellerito, Raffaele; Denton, Christopher; Damjanov, Nemanja; Henes, Jörg; Ortiz Santamaria Granollers, Vera; Kohm, Michaela; Stamenkovic, Bojana | |
| Phenotypic and functional analysis at the clonal level of infiltrating T lymphocytes in papillary carcinoma of the thyroid: prevalence of cytolytic T cells with natural killer-like or lymphokine-activated killer activity | 1-gen-1989 | Bagnasco, M; Venuti, D; Paolieri, F; Torre, G; Ferrini, S; Canonica, Gw | |
| Phenotypic and genotypic Helicobacter pylori clarithromycin resistance and therapeutic outcome: benefits and limits | 1-gen-2010 | De Francesco, V; Zullo, A; Ierardi, E; Giorgio, F; Perna, Francesco; Hassan, Cesare; Morini, S; Panella, C; Vaira, D. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile